Shortening the vaccine development cycle by reducing the need for costly, time-consuming manual analyses of vaccine potency is allowing pharma and biotech companies to increase their throughput. Using this strategy, automation can help to ensure that the most effective vaccines reach the market more rapidly.
Download as PDF file
